Archived — Canadian asset map for stem cell and regenerative medicine
Conclusion and acknowledgements
- Executive summary
- Overview of stem cell and regenerative medicine research in Canada
- Focus of stem cell and tissue engineering researchers
- Diseases/conditions targeted by stem cell and regenerative medicine researchers
- Relevant support facilities
- Key researchers and institutions
- Conclusion and acknowledgements
- References and notes
- Appendix 1 to 4: PDF version (1,195 KB, 96 pages)
In keeping with the fact that Canadian researchers were the first to identify many types of stem cells, Canada has a significant number of current researchers in this field (416 in professor or associate professor positions), many of them internationally renowned. Canada remains among the world leaders in stem cell research, with Ontario, and the University of Toronto in particular, having the greatest number of researchers and highest levels of funding. Researchers' main area of focus is tissue-specific stem cells (not embryonic stem cells as may have been assumed), particularly hematopoietic, and the most common disease area targeted is cancer. However, a number of other disease areas are also important, particularly neurological, musculoskeletal, and cardiovascular conditions.
We would like to thank everyone who participated in the creation of this document including Eric Cloutier, Policy Advisor, Life Science Industries Branch, Industry Sector, Industry Canada; Sue Kingsley, President, International BioPharma Solutions Ltd. (IBPS); Richard Taylor, via IBPS; Helen Kingsley, via IBPS; Drew Lyall, Executive Director, Canadian Stem Cell Network and Board of Directors of the Canadian Stem Cell Foundation and Canadian Stem Cell Consortium; Michael Rudnicki, Scientific Director, Canadian Stem Cell Network and Senior Scientist and Director of the Regenerative Medicine Program and the Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute; Cindy Bell, Interim Executive Director, Cancer Stem Cell Consortium and Executive VP Corporate Development, Genome Canada; Gordon Keller, Canada Research Chair in Embryonic Stem Cell Biology, Director, McEwen Centre for Regenerative Medicine, University Health Network, University of Toronto; Juan Carlos Zúñiga-Pflücker, Director of the Advanced Regenerative Tissue Engineering Centre, University of Toronto; Jim Till, President, Cancer Stem Cell Consortium and Board of Directors of the Canadian Stem Cell Foundation.
- Date modified: